Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Biochemical Pharmacology|October 17, 1998
Antiproliferative and differentiating effects of benzodiazepine receptor ligands on B16 melanoma cellsM Landau, A Weizman, E Zoref-Shani, et al.
Investigational New Drugs|December 16, 1998
Activity of pivaloyloxymethyl butyrate, a novel anticancer agent, on primary human tumor colony-forming unitsL L Siu, D D Von Hoff, A Rephaeli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A cell line with unusual characteristics from an ovarian carcinoma patient: modulation of sensitivity to antitumour drugsL Wasserman, R Aviram, H Levavi, et al.
Breast Cancer Research and Treatment|January 5, 2002
Role of transforming growth factor beta in the growth inhibition of human breast cancer cells by basic fibroblast growth factorE Fenig, Y Kanfi, Q Wang, et al.
Genomics|December 3, 2014
The effects of telomere shortening on cancer cells: a network model of proteomic and microRNA analysisO Uziel, N Yosef, R Sharan, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 12, 2012
A histone deacetylase inhibitory prodrug - butyroyloxymethyl diethyl phosphate - protects the heart and cardiomyocytes against ischemia injuryG Kessler-Icekson, E Hochhauser, T Sinai, et al.
British Journal of Cancer|May 5, 2005
Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell linesO Uziel, E Fenig, J Nordenberg, et al.
European Journal of Medicinal Chemistry|March 7, 2001
Prodrugs of butyric acid. Novel derivatives possessing increased aqueous solubility and potential for treating cancer and blood diseasesA Nudelman, E Gnizi, Y Katz, et al.
British Journal of Cancer|November 22, 2012
Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivoC Weiss, O Uziel, O Wolach, et al.
Pageof 8